Aptevo Therapeutics Inc. Quarterly Operating Income (Loss) in USD from Q1 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aptevo Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2015 to Q2 2024.
  • Aptevo Therapeutics Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$6.02M, a 26.3% increase year-over-year.
  • Aptevo Therapeutics Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$26M, a 17.4% increase year-over-year.
  • Aptevo Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$28.9M, a 0.83% decline from 2022.
  • Aptevo Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$28.6M, a 33.8% decline from 2021.
  • Aptevo Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$21.4M, a 22.2% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$26M -$6.02M +$2.15M +26.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$28.1M -$6.98M +$773K +9.97% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$28.9M -$6.38M +$1.3M +16.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$30.2M -$6.56M +$1.22M +15.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$31.4M -$8.18M -$616K -8.15% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$30.8M -$7.76M -$2.15M -38.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$28.6M -$7.68M -$3.64M -90.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$25M -$7.78M -$3.03M -63.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$22M -$7.56M -$1.84M -32.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$20.1M -$5.61M +$1.28M +18.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$21.4M -$4.04M +$2.78M +40.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$24.2M -$4.75M +$1.5M +24% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$25.7M -$5.72M +$1.09M +15.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$26.8M -$6.89M +$734K +9.63% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$27.5M -$6.82M -$1.65M -32% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$25.8M -$6.25M +$5.21M +45.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$31.1M -$6.81M +$6.09M +47.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$37.1M -$7.62M +$3.82M +33.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$41M -$5.17M +$8.43M +62% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$49.4M -$11.5M +$668K +5.51% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$50.1M -$12.9M -$452K -3.63% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 -$49.6M -$11.4M +$2.06M +15.3% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$51.7M -$13.6M +$3.23M +19.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 -$54.9M -$12.1M -$1.78M -17.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$53.1M -$12.4M +$2.21M +15.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$55.3M -$13.5M -$1.37M -11.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$53.9M -$16.8M -$2.27M -15.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$51.7M -$10.3M +$80.2M +88.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$132M -$14.6M -$1.8M -14% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$130M -$12.1M +$850K +6.55% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$131M -$14.6M +$3.95M +21.3% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-31
Q3 2016 -$135M -$90.5M -$77.3M -586% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$57.5M -$12.8M +$5.47M +29.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$63M -$13M -$1.88M -16.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$61.1M -$18.5M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$13.2M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$18.3M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-31
Q1 2015 -$11.1M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.